Entrectinib treatment induces a durable response against ARHGEF11::NTRK1 fusion gene‐positive spinal cord diffuse pediatric‐type high‐grade glioma

Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.